Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 12.12
+0.14 (1.17%)
Oct 16, 2026, 3:00 PM CST
Zhejiang Medicine Market Cap
Zhejiang Medicine has a market cap or net worth of 11.49 billion as of October 16, 2026. It is the 7,334th most valuable company in the world and the 1,408th biggest in China. Its market cap has decreased by 16.76% in one year.
Market Cap
11.49B
Enterprise Value
8.85B
Revenue
8.94B
Global Rank
Country Rank
#1,408 China
PE Ratio
14.44
ChartMarket Cap Chart
Since January 2, 2001, Zhejiang Medicine's market cap has increased from 5.53B to 11.49B, an increase of 107.65%. That is a compound annual growth rate of 2.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 11.49B | -12.55% |
| Dec 31, 2025 | 13.14B | -13.86% |
| Dec 31, 2024 | 15.25B | 48.35% |
| Dec 29, 2023 | 10.28B | -8.23% |
| Dec 30, 2022 | 11.20B | -31.56% |
| Dec 31, 2021 | 16.37B | 25.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 12.37B |
| Guobang Pharma | 12.23B |
| Henan Lingrui Pharmaceutical | 11.94B |
| Beijing Aosaikang Pharmaceutical | 11.81B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.47B |
| Porton Pharma Solutions | 11.30B |
| Shanghai Shyndec Pharmaceutical | 11.17B |
| Zhejiang CONBA Pharmaceutical | 10.84B |